Document is current
Any future updates will be listed below
-
Authors
Arshad, Muhammad Sameer
Kittipibul, Veraprapas
Fudim, Marat
- License Information
-
More Information
Article History
Accepted: 11 July 2025
First Online: 21 July 2025
Declarations
:
: Dr Fudim was supported by the NIH, Bodyport, Sardocor, and Doris Duke. He is a consultant/has ownership interesting in Abbott, Ajax, Alio Health, Alleviant, Analog, Andera, Artha, Audicor, AxonTherapies, Bayer, Bodyguide, Bodyport, Boston Scientific, Broadview, Cadence, Cardioflow, Coridea, CVRx, Daxor, Edwards LifeSciences, Echosens, EKO, Feldschuh Foundation, Fire1, FutureCardia, Galvani, Gradient, Hatteras, HemodynamiQ, Impulse Dynamics, Intershunt, Medtronic, Merck, NIMedical, NovoNordisk, NucleusRx, NXT Biomedical, Orchestra, Pharmacosmos, Presidio, Procyreon, Proton Intelligence, ReCor, Rockley, SCPharma, Shifamed, Splendo, STAT Health, Summacor, SyMap, Verily, Vironix, Viscardia, Zoll. Dr. Arshad and Dr. Kittipibul report no relevant disclosures.
